Home » News Feeds
News Feeds
Patient safety, news and press releases from EMA
- Fri, 25 Jul 2014 11:00:02 +0000: News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 July 2014 – Patient safety, news and press releases: human and vet
This page provides an overview of the opinions adopted at the July 2014 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.
- Fri, 25 Jul 2014 11:00:01 +0000: News and press releases: European Medicines Agency recommends approval of two new treatment options for rare cancers – Patient safety, news and press releases: human and vet
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), at its July meeting, recommended granting marketing authorisations for two new medicines with novel mechanisms of action for the treatment of different forms of rare cancers of the blood.
- Fri, 25 Jul 2014 10:05:00 +0000: News and press releases: World Hepatitis Day – European Medicines Agency uses regulatory tools to facilitate patient access to innovative medicines – Patient safety, news and press releases: human and vet
According to the World Health Organization (WHO), viral hepatitis kills 1.4 million people worldwide every year.
- Thu, 24 Jul 2014 13:15:00 +0000: News and press releases: European Medicines Agency launches public consultation on rules of procedures for public hearings – Patient safety, news and press releases: human and vet
The European Medicines Agency has today launched a public consultation on draft rules of procedures for public hearings held by its Pharmacovigilance Risk Assessment Committee (PRAC).
- Thu, 24 Jul 2014 11:00:01 +0000: News and press releases: Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight – Patient safety, news and press releases: human and vet
The European Medicines Agency has concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether increased bodyweight affects the effectiveness of these medicines in preventing unintended pregnancy following unprotected sexual intercourse or contraceptive failure.
MedWatch Safety Alert RSS Feed
- Fri, 25 Jul 2014 16:00:00 +0000: GE Healthcare, LLC, Single-Width Airway Modules (E-MiniC) and Accessories and Extension Modules (N-FC, N-FCREC): Class I Recall – CO2 Detector May Fail Leading to Injury – MedWatch Safety Alert RSS Feed
Physicians may make decisions based on incorrect values which could lead to permanent, irreversible impairment or life-threatening changes in patients.
- Tue, 22 Jul 2014 19:30:00 +0000: Advocate Redi-Code+ Blood Glucose Test Strips by Diabetic Supply of Suncoast: Recall- Labeling Error – MedWatch Safety Alert RSS Feed
UPDATED 07/22/2014. Recall classified as Class I. Delayed or inappropriate treatment of hyperglycemic or hypoglycemic states due to missed/delayed detection could lead to serious health consequences, including death.
- Mon, 21 Jul 2014 18:30:00 +0000: Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall – Mislabeled Packaging – MedWatch Safety Alert RSS Feed
Failure to receive the proper dose of oxcarbazepine could increase the chances of patients having a seizure and inadvertent consumption of ibuprofen may cause adverse reactions.
- Sat, 19 Jul 2014 04:00:00 +0000: Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): Drug Alert – Lack of Sterility Assurance – MedWatch Safety Alert RSS Feed
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death
- Fri, 18 Jul 2014 15:30:00 +0000: Baxter IV Sodium Chloride and Potassium Chloride Solutions: Recall – Particulate Matter – MedWatch Safety Alert RSS Feed
If infused, the presence of particulate foreign matter may elicit inflammatory and allergic responses, both chronic and acute, and may be life threatening.